How should I evaluate a patient with cardiogenic shock?

Evaluation of Patient with Cardiogenic Shock

A patient with suspected cardiogenic shock requires immediate ECG and echocardiography, followed by invasive arterial line monitoring, with cardiac output assessment reserved for those not responding to initial therapy. 1, 2

Immediate Diagnostic Assessment

Clinical Diagnosis

Cardiogenic shock is defined by:

• Hypotension: SBP < 90 mmHg for > 30 minutes despite adequate volume status
• Signs of hypoperfusion:
  • Oliguria (< 0.5 ml/kg/h for ≥ 6 hours)
  • Cold peripheries with livedo reticularis
  • Altered mental status
  • Lactate > 2 mmol/L
  • Metabolic acidosis
  • SvO₂ < 65% 1

First-Line Diagnostic Studies (Immediate)

ECG and echocardiography are required immediately in all patients with suspected cardiogenic shock 1. Echocardiography serves as the first-line imaging modality to assess shock type and hemodynamic status 2, as it can virtually rule out cardiac causes if it shows normal biventricular function, normal chamber dimensions, no significant valvular pathology, and no pericardial effusion 3.

Invasive Monitoring

Arterial line placement is needed immediately 1. For patients not responding to initial therapy or requiring vasopressors, both arterial and central venous catheter insertion are recommended 2.

Advanced Hemodynamic Assessment

When to Escalate Monitoring

Cardiac output and/or stroke volume should be monitored in patients who do not respond to initial therapy to assess shock type, evaluate hemodynamic status, and determine therapeutic response 2. This represents a critical decision point—if the patient stabilizes with initial fluid challenge and basic interventions, advanced monitoring may not be necessary.

How to Monitor Cardiac Output

The 2025 ESICM guidelines provide the most current framework 2:

For complex patients requiring CO monitoring:

• Echocardiography first as the preferred initial modality over invasive technologies 2
• Serial echocardiographic evaluations should continue even when CO is monitored by other means 2

For invasive CO monitoring when needed:

• Transpulmonary thermodilution or pulmonary artery catheter (PAC) may be considered 2
• In complex patients: Use PAC or transpulmonary thermodilution to determine shock type 2

Specific clinical scenarios for advanced monitoring:

• RV failure: PAC is preferred because it measures pulmonary artery pressure 2
• Without RV failure: Transpulmonary thermodilution is preferred because it measures extravascular lung water 2
• Refractory shock with RV dysfunction: PAC is suggested 2
• Severe shock with ARDS: Transpulmonary thermodilution or PAC suggested 2

Interpreting Hemodynamic Data

When CO is monitored, its adequacy must be interpreted by evaluating organ function, tissue oxygenation, metabolism, and perfusion—not just the number itself 2. Frequent reevaluation is recommended as shock is a dynamic state 2.

Phenotyping the Shock

Key Hemodynamic Parameters to Assess

Once invasive monitoring is established, determine the shock phenotype:

Biventricular vs. LV-dominant vs. RV-dominant shock 4:

• Cardiac Power Output (CPO): < 0.6 W indicates severe shock
• Pulmonary Artery Pulsatility Index (PAPi): < 1.0 suggests RV dysfunction
• Right atrial pressure: > 15 mmHg indicates RV involvement
• PCWP: > 15 mmHg indicates elevated LV filling pressures

This phenotyping is critical because it determines whether the patient needs LV support, RV support, or biventricular support 4.

Common Pitfalls

Important caveats:

• While the 2015 guidelines state "there is no agreement on optimal method of hemodynamic monitoring" including PAC use 1, the 2025 ESICM guidelines provide more specific recommendations favoring echocardiography first, then selective use of PAC or transpulmonary thermodilution based on clinical context 2
• Do not delay echocardiography—it should be performed immediately, not after other tests 1
• Fluid challenge (saline or Ringer's lactate > 200 ml over 15-30 minutes) is recommended first-line if no overt fluid overload 1—assess response before escalating monitoring
• Normal echocardiography essentially rules out cardiogenic shock, avoiding unnecessary invasive procedures 3

Algorithmic Approach

1. Suspect cardiogenic shock (hypotension + hypoperfusion signs)
2. Immediate: ECG + echocardiography + arterial line 1
3. If no overt overload: Fluid challenge 200+ ml over 15-30 min 1
4. If responds to initial therapy: Continue clinical monitoring with serial echo
5. If no response to initial therapy:
   • Add central venous access 2
   • Initiate CO monitoring (echo-based preferred initially) 2
   • Consider PAC or transpulmonary thermodilution based on RV involvement 2
6. Phenotype the shock using hemodynamic parameters to guide device selection 4
7. Frequent reassessment of CO and organ perfusion 2